Patent Number: 8,877,707

Title: Inhibitors of HCV NS5A

Abstract: Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.

Inventors: Zhong; Min (San Francisco, CA), Li; Leping (San Francisco, CA)

Assignee: Presidio Pharmaceuticals, Inc.

International Classification: A01N 37/18 (20060101); A61K 38/00 (20060101); A61P 1/16 (20060101)

Expiration Date: 2019-11-04 0:00:00